Inventor · Urbana, MD, US

Mitchell Ho

19Patents
7h-index
20Co-inventors
62Inventor score

Filing activity: Nov 24, 2004 → Sep 20, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9416190B2 Mesothelin antibodies and methods for eliciting potent antitumor activity Physics 20 Active
US9409992B2 Mesothelin domain-specific monoclonal antibodies and use thereof Physics 13 Active
US9409994B2 High-affinity monoclonal antibodies to glypican-3 and use thereof Physics 12 Active
US7982011B2 Mutated anti-cd22 antibodies and immunoconjugates Chemistry; Metallurgy 12 Active
US9803022B2 Mesothelin domain-specific monoclonal antibodies and use thereof Physics 12 Active
US8460660B2 Anti-mesothelin antibodies Chemistry; Metallurgy 11 Active
US9394364B2 Human monoclonal antibodies specific for glypican-3 and use thereof Physics 10 Active
US9206257B2 Human monoclonal antibodies specific for glypican-3 and use thereof Physics 5 Active
US11066479B2 Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof Chemistry; Metallurgy 1 Active
US11390683B2 Anti-mesothelin polypeptides and proteins Chemistry; Metallurgy 1 Active
US8623828B2 Blocking mesothelin peptide fragments Chemistry; Metallurgy 1 Active
US9932406B2 Human monoclonal antibodies specific for glypican-3 and use thereof Physics 0 Active
US11795235B2 Immunotoxins with albumin binding domain Chemistry; Metallurgy 0 Active
US10640571B2 Human monoclonal antibodies specific for glypican-3 and use thereof Physics 0 Active
US12215164B2 Immunotoxins with albumin binding domain Chemistry; Metallurgy 0 Active
US12122843B2 High affinity monoclonal antibodies targeting glypican-1 and methods of use Chemistry; Metallurgy 0 Active
US12012463B2 High affinity monoclonal antibodies targeting glypican-2 and uses thereof Chemistry; Metallurgy 0 Active
US12180296B2 Cross species single domain antibodies targeting mesothelin for treating solid tumors Chemistry; Metallurgy 0 Active
US11802163B2 Chimeric antigen receptors targeting glypican-3 or mesothelin Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.